CV:

Ravi Kalyanaraman is the director of Global Quality Analytical Science and Technology (GQAST) at Bristol-Myers Squibb Company in New Brunswick, NJ, USA. He received his Ph.D. in Chemistry from University of Idaho in 1995 and did his postdoctoral work at the University of Puerto Rico. He was a faculty member in the department of chemistry at Bemidji State University in Bemidji, Minnesota from 1997 till 2001. He has been with Bristol-Myers Squibb since 2002 and in the last seventeen years he has been focusing on using novel techniques to detect pharmaceutical counterfeits and to support manufacturing investigations. He leads a team of quality scientists that are involved in providing analytical support for manufacturing and suspect product investigations and also for quality control release testing methods. His ground breaking work in pharmaceutical forensics has been recognized all across the globe and Ravi has been invited to present at several conferences, both nationally and internationally and also been asked to write articles in journals and magazines. He has published nine articles and has given more than 40 talks at several conferences in the past 10 years.

The Pop in your Job: What drives you? What is your passion?:

I come to work everyday without knowing what I am going to be getting into, but I do know that I will be facing a new challenge every day. My work is like Tom Hanks saying in Forrest Gump, Life (my work) is like a box of chocolates, you never know what you are going to get :). But at the end of the day, I go home telling myself that I had made a difference today in safe gaurding patients and my company.

Bristol-Myers Squibb is a global biopharmaceutical company focused on discovering, developing and delivering innovative medicines for patients with serious diseases. Our medicines are helping millions of patients around the world in disease areas such as oncology, cardiovascular, immunoscience, fibrosis and others. We have built a sustainable pipeline of potential therapies, and are leveraging translational medicine and data analytics to understand how we can deliver the right medicine to the right patient at the right time to achieve the best outcome. Through the Bristol-Myers Squibb Foundation, we also promote health equity and seek to improve health outcomes of populations disproportionately affected by serious diseases and conditions, giving new hope to some of the world’s most vulnerable people. Each day, our employees around the world work together for patients – it drives everything we do.